Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic mice expressing human CD20 and/or CD16

Transgenic mice expressing human CD20 and/or CD16

US Patent 7402728 · Granted Jul 22, 2008

Estimated economic value: $263,476,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Terminal structure for conduction cooling high temperature superconducting cable2023
Online sensor calibration for autonomous vehicles2023
Composition and methods for the diagnosis of immune related diseases involving t2018
Composition and methods for the diagnosis of immune related diseases involving t2018
Golf push trolley2018
Methods for treating, diagnosing, and monitoring rheumatoid arthritis2017
Composition and methods for the diagnosis of immune related diseases involving t2017
Methods and compositions related to B cell assays2017
Methods for treating, diagnosing, and monitoring rheumatoid arthritis2014
Apoptotic anti-IgE antibodies2014
Methods for use with BAFF antagonists2013
Immunoglobulin variants and uses thereof2013